Why Ferrari N.V. (RACE) Is Surging in 2025
We recently published an article titled Why These 15 Vehicles & Parts Stocks Are Surging In 2025. In this article, we are going to take a look at where Ferrari N.V. (NYSE:RACE) stands against the other vehicles and parts stocks.
Certain automotive companies have held up surprisingly well in the current environment, and that's especially true with companies that supply automotive parts. The high interest rate regime was supposed to crush automotive companies across the board, and early tariffs specifically targeted countries that produced the most automotive parts for the U.S.
Even then. These stocks have done well since high interest rates have made it difficult for low-income consumers to buy new cars. Instead, they have opted for repairing their existing vehicles, which has been a tailwind for automotive parts companies for the past two years. The average age of vehicles was already at a record 12.6 years in 2024, so this tailwind isn't going away anytime soon.
Customers who have higher incomes have kept on buying new vehicles. It is mostly because of them that consumer spending has held up across the board. Here are the biggest winners from this trend.
Even during bear markets, there are pockets of the market that perform exceptionally well. For example, I identified 15 Financial Services Stocks that are up the Most in 2025 in another article.
Methodology
For this article, I screened the best-performing vehicles & parts stocks year-to-date.
I will also mention the number of hedge fund investors in these stocks. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
Jim Cramer on Ferrari N.V. (RACE)'s Luxury Advantage: 'No Resistance to Price'
A classic Ferrari sports car against a lush green hillside, symbolizing the company's luxurious performance.
Ferrari N.V. (NYSE:RACE)
Number of Hedge Fund Holders In Q4 2024: 37
Ferrari N.V. (NYSE:RACE) designs and manufactures high-performance luxury sports cars and competes in Formula 1 racing worldwide.
Ferrari N.V. (NYSE:RACE)'s stock has seen significant growth in 2025, primarily due to its strong financial performance and strategic commercial policy updates. In March 2025, Ferrari announced an update to its commercial policy regarding import tariffs on EU cars into the USA.
The company decided to maintain unchanged commercial terms for orders of all models imported before April 2, 2025, and for three specific model families (Ferrari 296, SF90, and Roma), regardless of import date. For other current models, Ferrari N.V. (NYSE:RACE) implemented a maximum 10% price increase in coordination with its dealer network. Despite these tariff challenges, Ferrari confirmed its financial targets for 2025, noting only a potential risk of 50 basis points reduction in profitability percentage margins.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
AM Best Revises Outlooks to Negative for UnitedHealth Group Incorporated and Its Subsidiaries
OLDWICK, N.J., June 04, 2025--(BUSINESS WIRE)--AM Best has revised the outlooks to negative from stable and affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IRs) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) [NYSE: UNH]. AM Best also has affirmed the Short-Term IR of UnitedHealth Group. Concurrently, AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. (See link below for a detailed listing of the companies and ratings.) The ratings reflect UnitedHealthcare's balance sheet strength, which AM Best assesses as strong, as well as its very strong operating performance, very favorable business profile and appropriate enterprise risk management (ERM). The revision of the outlooks to negative from stable reflects the expected deterioration in operating performance in 2025 driven by the Medicare Advantage segment. In UnitedHealth Group's first-quarter earnings, the company noted an acceleration in trends in the Medicare Advantage segment that occurred late in the quarter. In May 2025, the company announced that trends continued to accelerate and broadened to more types of benefit offerings. Additionally, UnitedHealth Group noted that the medical costs of many Medicare Advantage beneficiaries new to UnitedHealthcare remained higher than expected. Due to the design of the Medicare Advantage program, UnitedHealthcare is unable to implement corrective pricing actions until 2026, and the issues within the Medicare Advantage segment are expected to persist for the remainder of 2025. AM Best will continue to monitor UnitedHealth Group's operating performance and may take rating action should operating performances no longer be in line with the very strong assessment. UnitedHealthcare's risk-adjusted capitalization, as measured by Best's Capital Adequacy Ratio, is at the very strong level. Capital and surplus growth is supported by retained net earnings in excess of dividends to the parent. UnitedHealthcare actively manages subsidiary risk-adjusted capital on a near- to long-term basis to ensure capital levels are supportive of premium growth. Investment risk is on the low side with a conservative asset allocation and no material exposure to equities, real estate or schedule BA assets. UnitedHealthcare holds a substantial market share in all lines of business and on a national basis. Premiums and earnings are well-diversified by business segment and geography. Furthermore, its large membership base provides economies of scale. UnitedHealth Group's ERM program is developed, and the group's risk management capabilities are aligned with its risk profile. The ERM program is dynamic and utilized in daily operations and strategic business planning. However, AM Best recognizes the missteps that have occurred within the organization, including the Change Healthcare cyber-attack as well as the issues addressed in the recent earnings announcements. AM Best evaluates UnitedHealth Group's ERM as appropriate. UnitedHealth Group has strong financial flexibility with material non-regulated operating cash flows from its Optum operations. Equity has shown consistent growth over the past five years, driven entirely by retained earnings despite large share repurchases and growing dividend programs. Strong liquidity is driven by favorable operating cash flows, parent company cash, a commercial paper program and a $21 billion revolving credit facility. Financial leverage at year-end 2024 was elevated at 43.7%, as measured by AM Best, and is above the company's long-term target of 40%. Additionally, earnings before interest and tax coverage remained good but declined in 2024 to about eight times. Furthermore, UnitedHealth Group had a large amount of goodwill and intangibles on the balance sheet totaling approximately 132% of equity. There has been no history of any material impairments and acquired assets continue to contribute favorably to revenues and earnings. A complete listing of UnitedHealth Group's FSRs and Long-Term ICRs, as well as Short- and Long-Term IRs, is available. This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments. AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED. View source version on Contacts Bridget Maehr Director +1 908 882 2080 Sally Rosen Senior Director +1 908 882 2284 Christopher Sharkey Associate Director, Public Relations +1 908 882 2310 Al Slavin Senior Public Relations Specialist +1 908 882 2318 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
31 minutes ago
- Business Wire
AM Best Revises Outlooks to Negative for UnitedHealth Group Incorporated and Its Subsidiaries
BUSINESS WIRE)-- AM Best has revised the outlooks to negative from stable and affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of 'a' (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IRs) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) [NYSE: UNH]. AM Best also has affirmed the Short-Term IR of UnitedHealth Group. Concurrently, AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of 'aa-' (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. (See link below for a detailed listing of the companies and ratings.) The ratings reflect UnitedHealthcare's balance sheet strength, which AM Best assesses as strong, as well as its very strong operating performance, very favorable business profile and appropriate enterprise risk management (ERM). The revision of the outlooks to negative from stable reflects the expected deterioration in operating performance in 2025 driven by the Medicare Advantage segment. In UnitedHealth Group's first-quarter earnings, the company noted an acceleration in trends in the Medicare Advantage segment that occurred late in the quarter. In May 2025, the company announced that trends continued to accelerate and broadened to more types of benefit offerings. Additionally, UnitedHealth Group noted that the medical costs of many Medicare Advantage beneficiaries new to UnitedHealthcare remained higher than expected. Due to the design of the Medicare Advantage program, UnitedHealthcare is unable to implement corrective pricing actions until 2026, and the issues within the Medicare Advantage segment are expected to persist for the remainder of 2025. AM Best will continue to monitor UnitedHealth Group's operating performance and may take rating action should operating performances no longer be in line with the very strong assessment. UnitedHealthcare's risk-adjusted capitalization, as measured by Best's Capital Adequacy Ratio, is at the very strong level. Capital and surplus growth is supported by retained net earnings in excess of dividends to the parent. UnitedHealthcare actively manages subsidiary risk-adjusted capital on a near- to long-term basis to ensure capital levels are supportive of premium growth. Investment risk is on the low side with a conservative asset allocation and no material exposure to equities, real estate or schedule BA assets. UnitedHealthcare holds a substantial market share in all lines of business and on a national basis. Premiums and earnings are well-diversified by business segment and geography. Furthermore, its large membership base provides economies of scale. UnitedHealth Group's ERM program is developed, and the group's risk management capabilities are aligned with its risk profile. The ERM program is dynamic and utilized in daily operations and strategic business planning. However, AM Best recognizes the missteps that have occurred within the organization, including the Change Healthcare cyber-attack as well as the issues addressed in the recent earnings announcements. AM Best evaluates UnitedHealth Group's ERM as appropriate. UnitedHealth Group has strong financial flexibility with material non-regulated operating cash flows from its Optum operations. Equity has shown consistent growth over the past five years, driven entirely by retained earnings despite large share repurchases and growing dividend programs. Strong liquidity is driven by favorable operating cash flows, parent company cash, a commercial paper program and a $21 billion revolving credit facility. Financial leverage at year-end 2024 was elevated at 43.7%, as measured by AM Best, and is above the company's long-term target of 40%. Additionally, earnings before interest and tax coverage remained good but declined in 2024 to about eight times. Furthermore, UnitedHealth Group had a large amount of goodwill and intangibles on the balance sheet totaling approximately 132% of equity. There has been no history of any material impairments and acquired assets continue to contribute favorably to revenues and earnings. A complete listing of UnitedHealth Group's FSRs and Long-Term ICRs, as well as Short- and Long-Term IRs, is available.
Yahoo
an hour ago
- Yahoo
Norfolk Southern to present at 2025 Wells Fargo Industrials and Materials Conference
ATLANTA, June 4, 2025 /PRNewswire/ -- Norfolk Southern Corporation (NYSE: NSC) Executive Vice President and Chief Operating Officer John Orr and Executive Vice President and Chief Financial Officer Jason Zampi will participate in a fireside chat at the 2025 Wells Fargo Industrials and Materials Conference. Details on how to listen to the discussion follow below. What: 2025 Wells Fargo Industrials and Materials ConferenceWhen: Tuesday, June 10, 2025 at 11:15 a.m. ETWhere: Via Webcast The presentation will be posted at on the Investors page. About Norfolk SouthernSince 1827, Norfolk Southern Corporation (NYSE: NSC) and its predecessor companies have safely moved the goods and materials that drive the U.S. economy. Today, it operates a 22-state freight transportation network. Committed to furthering sustainability, Norfolk Southern helps its customers avoid approximately 15 million tons of yearly carbon emissions by shipping via rail. Its dedicated team members deliver approximately 7 million carloads annually, from agriculture to consumer goods. Norfolk Southern also has the most extensive intermodal network in the eastern U.S. It serves a majority of the country's population and manufacturing base, with connections to every major container port on the Atlantic coast as well as major ports across the Gulf Coast and Great Lakes. Learn more by visiting View original content to download multimedia: SOURCE Norfolk Southern Corporation
